6-溴-1,4-二噁螺[4.6]十一烷 | 70562-63-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 6-溴-1,4-二噁螺[4.6]十一烷
• 中文别名: 6-溴-1,4-二氧杂螺[4.6]十一烷
• 英文名称: 2-Brom-cycloheptanon-ethylenketal
• 英文别名: 6-Bromo-1,4-dioxaspiro[4.6]undecane
• CAS: 70562-63-9
• 化学式: C₉H₁₅BrO₂
• 分子量: 235.121
• InChiKey: CUPUHWFXOULUCT-UHFFFAOYSA-N

物化性质

• 沸点：
  287℃
• 密度：
  1.40
• 闪点：
  125℃

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2932999099

反应信息

• 作为反应物：
  描述：

  6-溴-1,4-二噁螺[4.6]十一烷 在 盐酸 、 sodium hydroxide 、 sodium tetrahydroborate 、 chromium trioxide pyridine 、 Celite 、 potassium tert-butylate 、 mercury(II) diacetate 作用下， 以 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 12.5h， 生成 1,3-环庚二酮
  参考文献：
  名称：

  Bhushan, Vidya; Chandrasekaran, S., Synthetic Communications, 1984, vol. 14, # 4, p. 339 - 346

  摘要：

  DOI：
• 作为产物：
  描述：

  环庚酮 生成 6-溴-1,4-二噁螺[4.6]十一烷
  参考文献：
  名称：

  DUCROT, P. -H.;BEAUHAIRE, J.;LALLEMAND, J. Y., TETRAHEDRON LETT., 31,(1990) N7, C. 3883-3886

  摘要：

  DOI：

文献信息

• Optimization of Grignard ring-opening of α-brominated dioxolanes for the preparation of β-hydroxy-protected vinyl ethers by a three-step one-pot procedure
  作者：Mathieu André、Boris Letribot、Martine Bayle、Emmanuelle Mounetou、Jean-Michel Chezal

  DOI：10.1016/j.tetlet.2012.08.144

  日期：2012.11

  Aliphatic, cyclic, and aromatic benzoate-protected γ-hydroxy enol ethers were prepared from α-brominated dioxolanes by a three-step reaction procedure and a one-pot protocol involving Grignard reagent formation, ring-opening, and final benzoate protection. Additionally, tert-butyldiphenylsilyl, acetate, and 4,4′-dimethoxytrityl were also successfully used as alternative protecting groups.

  脂族，环状和芳族苯甲酸酯保护的γ-羟基烯醇醚是通过三步反应程序和涉及格氏试剂形成，开环和最终苯甲酸酯保护的一锅法从α-溴化二氧戊环制备的。另外，叔丁基二苯基甲硅烷基，乙酸盐和4,4'-二甲氧基三苯甲基也被成功地用作替代的保护基。
• Synthesis and Application of Poly(diallyldimethylammonium tribromide) as a Novel Polymeric Brominating Agent
  作者：Mahdavi Hossein、Kachoei Zahra

  DOI：10.1002/cjoc.201090367

  日期：2010.11

  In this study, the synthesis and applications of a new supported tribromide reagent based on poly(diallyldimethylammonium chloride) is reported. This supported tribromide is used in α‐bromoacetalization of ketones, bromination of alkenes and regioselective bromination of activated aromatic compounds. This method is mild and no Br2 and HBr were used. Other advantages of this reagent are stability, high

  在这项研究中，报道了基于聚二烯丙基二甲基氯化铵的新型负载型三溴化试剂的合成和应用。这种负载的三溴化物用于酮的α-溴缩醛化，烯烃的溴化和活化的芳香族化合物的区域选择性溴化。该方法温和，不使用Br 2和HBr。该试剂的其他优点是稳定性，高效率，简单的可过滤性和可重复使用性。
• Certain fused pyrrolecarboxamides a new class of GABA brain receptor
  申请人：Neurogen Corporation

  公开号：US05723462A1

  公开（公告）日：1998-03-03

  Disclosed are compounds of formula I: ##STR1## wherein R.sub.8 and R.sub.9 independently represent hydrogen or organic substituents; W represents optionally substituted thiazolyl or quinoxalinyl; X is hydrogen, hydroxy or lower alkyl; and T is hydrogen, halogen, hydroxy, nitro, amino or alkyl, which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptor. These compounds are useful in the diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory.

  本发明公开了式I的化合物：##STR1## 其中R.sub.8和R.sub.9独立地代表氢或有机取代基；W代表可选取代的噻唑基或喹喔啉基；X是氢、羟基或低碳基；T是氢、卤素、羟基、硝基、氨基或烷基，这些化合物是高度选择性的GABAa脑受体激动剂、拮抗剂或反向激动剂或者是GABAa脑受体激动剂、拮抗剂或反向激动剂的前药。这些化合物在焦虑、睡眠和癫痫障碍、苯二氮平药物过量和增强记忆方面的诊断和治疗中非常有用。
• Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain
  申请人：Neurogen Corporation

  公开号：US05750702A1

  公开（公告）日：1998-05-12

  The present invention encompasses structures of the formula: ##STR1## or the pharmaceutically acceptable non-toxic salts thereof wherein: ##STR2## wherein: W represents substituted or unsubstituted phenyl; X is hydrogen, hydroxy or lower alkyl; T is hydrogen, halogen, hydroxy, nitro, amino or alkyl; R.sub.3 is hydrogen or an organic group; R.sub.4 is hydrogen or substituted or unsubstituted organic substituent; R.sub.5 and R.sub.6 represent organic, and inorganic substituents; and n is 1, 2, 3, or 4, which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors. These compounds are useful in the diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory.

  本发明涵盖以下结构或其药学上可接受的非毒性盐：##STR1## 其中：##STR2## 其中：W代表取代或未取代的苯基；X代表氢、羟基或较低的烷基；T代表氢、卤素、羟基、硝基、氨基或烷基；R.sub.3代表氢或有机基团；R.sub.4代表氢或取代或未取代的有机取代基；R.sub.5和R.sub.6代表有机和无机取代基；n为1、2、3或4。这些化合物是高度选择性的GABAa脑受体激动剂、拮抗剂或反向激动剂，或者是GABAa脑受体激动剂、拮抗剂或反向激动剂的前药。这些化合物在焦虑、睡眠和癫痫障碍、苯二氮平类药物过量和增强记忆方面的诊断和治疗中是有用的。
• Certain fused pyrrolecarboxamides; a new class of GABA brain receptor
  申请人：Neurogen Corporation

  公开号：US06096887A1

  公开（公告）日：2000-08-01

  The present invention encompasses structures of the formula I: ##STR1## or the pharmaceutically acceptable non-toxic salts thereof wherein: ##STR2## W represents substituted or unsubstituted heteroaryl; X is hydrogen, hydroxy or lower alkyl; T is hydrogen, halogen, hydroxy, nitro, amino or alkyl; R.sub.3 is hydrogen or an organic group; R.sub.4 is hydrogen or substituted or unsubstituted organic substituent; R.sub.5 and R.sub.6 represent organic, and inorganic substituents; and n is 1,2,3, or 4, which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors. These compounds are useful in the diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory.

  本发明涵盖以下结构的化合物I式：##STR1##或其药学上可接受的无毒盐，其中：##STR2##W代表取代或未取代的杂环芳基；X为氢、羟基或较低的烷基；T为氢、卤素、羟基、硝基、氨基或烷基；R.sub.3为氢或有机基团；R.sub.4为氢或取代或未取代的有机取代基；R.sub.5和R.sub.6代表有机和无机取代基；n为1、2、3或4。这些化合物是高度选择性的GABAa脑受体的激动剂、拮抗剂或反向激动剂，或是GABAa脑受体激动剂、拮抗剂或反向激动剂的前药。这些化合物在焦虑、睡眠和癫痫障碍的诊断和治疗、苯二氮卓类药物过量和增强记忆方面有用。